Chemistry:Trevogrumab
From HandWiki
Short description: Monoclonal antibody
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Human |
| Target | growth differentiation factor 8 |
| Clinical data | |
| Other names | REGN1033 |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C6374H9884N1696O2018S46 |
| Molar mass | 144037.80 g·mol−1 |
Trevogrumab (INN;[1] development code REGN1033) is a human monoclonal antibody designed for the treatment of muscle atrophy due to orthopedic disuse and sarcopenia.
This drug was developed by Regeneron Pharmaceuticals, Inc.[2]
References
- ↑ World Health Organization (2015). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 113". WHO Drug Information 29 (2). https://www.who.int/medicines/publications/druginformation/innlists/PL113.pdf.
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Trevogrumab, American Medical Association.
 |  |
